Login / Signup

Rationale and design of ProUrokinase in Mild IsChemic strokE (PUMICE): a multicentre, prospective, randomised, open-label, blinded-endpoint controlled trial.

Yun-Yun XiongManjun HaoYue-Song PanChunmiao DuanXueyan FengHao LiNa WuLiyuan WangXia MengXing-Quan ZhaoYong-Jun Wangnull null
Published in: Stroke and vascular neurology (2024)
NCT05507645.
Keyphrases
  • open label
  • study protocol
  • clinical trial
  • double blind
  • randomized controlled trial
  • placebo controlled
  • phase ii
  • phase iii
  • phase ii study
  • atrial fibrillation